What Alexion Pharmaceuticals, Inc. pays on H-1B filings

Alexion Pharmaceuticals, Inc. filed 78 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.

FY2026 so far · 35 LCAsFY2025 · 43 LCAs

Stated wages by title

TitleLCAsYearTypical rangeMedian
Associate Scientist12FY2026 so far$94,211 to $100,920$99,689
Associate Director5FY2026 so far$161,803 to $201,058$178,000
Scientist Injectable Drug Product Development4FY2026 so far$128,340 to $142,766$135,000
Associate Director3FY2026 so far$169,770 to $211,378$190,574

Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.

Filings by fiscal year

Fiscal yearCertified LCAs
FY2026 (October to June)35
FY202543

By prevailing-wage level

LevelLCAsMedian stated wage
Level I (entry)17$101,207
Level II (qualified)26$139,653
Level III (experienced)14$156,408
Level IV (fully competent)19$161,803
No level stated2$144,975

DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.

Top worksites

WorksiteLCAsMedian stated wage
New Haven, CT33$125,318
Boston, MA29$161,803
Cambridge, MA5$145,000

Looking at Alexion Pharmaceuticals, Inc.?

Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.